glp 1 agonist prediabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Nutritional priorities to support GLP-1

With the variety of capsule sizes, capsules can hold multiple nutritional ingredients, helping to minimize the amount of supplements needed to be manufactured or consumed

speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences

2023, doi: 10.1056/NEJMoa2307563

If you are considering GLP-1 therapy, genetic insights into peptide receptor and metabolic gene variants can support a more personalized conversation with your provider about which GLP-1 formulationcompounded semaglutide, tirzepatide, or dual GLP-Squaredmay align with your genetic predispositions

95% CI, 0.831.01)

Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme